Skip to main content

Biotechs are companies that can provide more benefits

Images

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

Last Sunday, Joan Rodés, director of the “Instituto de Investigaciones Sanitarias Clínic-IDIBAPS”, was interviewed in the special supplement of “La Vanguardia” about the current status of biotechnology and its future prospects. The article referred to the importance of translational research, clearly exemplified by the partnerships established between IRB Barcelona and the “Instituto de Investigaciones Sanitarias Clínic-IDIBAPS”.

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).